Abstract
To determine neutralizing activity against the severe acute respiratory syndrome coronavirus 2 ancestral strain and 4 variants of concern, we tested serum from 30 persons with breakthrough infection after 2-dose vaccination. Cross-variant neutralizing activity was comparable to that after 3-dose vaccination. Shorter intervals between vaccination and breakthrough infection correlated with lower neutralizing titers.
Keywords: 2019 novel coronavirus disease; B cell; COVID-19; SARS-CoV-2; coronavirus disease; immunity; mRNA; neutralizing antibody; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccines; viruses; zoonoses.
All Keywords
【저자키워드】 COVID-19, 2019 novel coronavirus disease, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, neutralizing antibody, SARS-CoV-2, Immunity, Vaccines, B cell, mRNA, 【초록키워드】 2019 novel coronavirus disease, coronavirus disease, respiratory infections, zoonoses, neutralizing antibody, coronavirus, vaccination, variants of concern, novel coronavirus disease, severe acute respiratory syndrome Coronavirus, Novel coronavirus, B cell, serum, Neutralizing activity, mRNA, Neutralizing, Breakthrough infection, respiratory, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, neutralizing titers, tested, determine, correlated, comparable, interval, 【제목키워드】 activity,
【저자키워드】 COVID-19, 2019 novel coronavirus disease, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, neutralizing antibody, SARS-CoV-2, Immunity, Vaccines, B cell, mRNA, 【초록키워드】 2019 novel coronavirus disease, coronavirus disease, respiratory infections, zoonoses, neutralizing antibody, coronavirus, vaccination, variants of concern, novel coronavirus disease, severe acute respiratory syndrome Coronavirus, Novel coronavirus, B cell, serum, Neutralizing activity, mRNA, Neutralizing, Breakthrough infection, respiratory, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, neutralizing titers, tested, determine, correlated, comparable, interval, 【제목키워드】 activity,
{{{ 추상적인 }}}
중증급성호흡기증후군 코로나바이러스 2 조상 균주 및 4가지 우려 변종에 대한 중화 활성을 확인하기 위해 2회 접종 후 돌발성 감염이 있는 30명의 혈청을 테스트했습니다. 교차 변형 중화 활성은 3회 백신 접종 후와 유사했습니다. 백신 접종과 돌발성 감염 사이의 더 짧은 간격은 더 낮은 중화 역가와 상관관계가 있었습니다.
{{ 키워드: }} 2019년 신종 코로나바이러스 감염증; B 세포; 코로나바이러스감염증-19 : 코로나19; 사스 코로나바이러스 2; 코로나바이러스 질환; 면역; mRNA; 중화 항체; 호흡기 감염; 중증 급성 호흡기 증후군 코로나바이러스 2; 백신; 바이러스; 인수공통전염병